Australian drug company Homart Pharmaceuticals has lost an appeal of a ruling that found the packaging of its bio-placenta skin care oil was intentionally and deceptively similar to a rival’s get-up, in breach of the consumer law.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au